CNMD · CONMED Corp

$50.41 +0.59 (+1.18%) At close · Aug 14

Market Cap

$1.51B

29.95M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Patrick J. Beyer	President and Chief Executive Officer	$891,100	—	$2,499,971	$2,499,977	$1,129,469	$614,356	$7,634,873
Todd Garner	CFO	$610,000	—	$500,096	$1,499,990	$659,354	$27,956	$3,297,396
Todd W. Garner	Executive Vice President, Finance and Chief Financial Officer	$610,000	—	$500,096	$1,499,990	$659,354	$27,956	$3,297,396
Hollie Foust	Executive Vice President, General Counsel and Corporate Secretary	$457,500	—	$250,005	$750,007	$378,159	$7,105	$1,842,776
Brent Lalomia	Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations	$424,499	$50,000	$218,721	$656,238	$276,073	$37,245	$1,662,776
Peter K. Shagory	Executive Vice President, Strategy and Corporate Development	$385,963	—	$212,534	$637,499	$320,529	$7,264	$1,563,789

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Curt Hartman	Chair, President & Chief Executive Officer	$966,230	$0	$2,657,542	$2,657,200	$882,622	$202,961	$7,366,555
Todd W. Garner	Executive Vice President, Finance and Chief Financial Officer	$565,776	$0	$2,099,933	$1,499,807	$397,860	$79,337	$4,642,713
Todd Garner	CFO	$565,776	—	$2,099,933	$1,499,807	$397,860	$79,337	$4,642,713
Patrick J. Beyer	Chief Operating Officer	$584,833	$0	$699,883	$2,099,802	$398,331	$517,236	$4,300,085
Heather L. Cohen	Executive Vice President & Chief Human Resources and Legal Officer & Secretary	$596,363	$0	$374,964	$1,124,864	$69,432	$85,085	$2,250,708
Peter K. Shagory	EVP Strategy & Corp Development	$368,725	$0	$212,551	$637,427	$198,230	$7,112	$1,424,045
Brent Lalomia	Vice President, Quality Assurance, Regulatory Affairs, Customer Experience, and Logistics Stanley W. (Bill) Peters President, Advanced Surgical & Advanced Endoscopic Technologies	$317,700	$0	$212,551	$637,427	$175,073	$49,608	$1,392,359

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Curt Hartman	Chair, President & Chief Executive Officer	$950,000	$0	$2,657,526	$2,657,441	$1,396,590	$103,058	$7,764,615
Patrick J. Beyer	Chief Operating Officer	$548,926	$0	$425,064	$1,274,951	$505,300	$545,070	$3,299,311
Todd W. Garner	Executive Vice President, Finance and Chief Financial Officer	$538,971	$0	$425,064	$1,274,951	$579,057	$53,821	$2,871,864
Todd Garner	CFO	$538,971	—	$425,064	$1,274,951	$579,057	$53,821	$2,871,864
Heather L. Cohen	Executive Vice President & Chief Human Resources and Legal Officer & Secretary	$420,000	$0	$249,944	$749,962	$361,397	$39,075	$1,826,811

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Curt Hartman	Chair, President & Chief Executive Officer	$946,055	$0	$0	$6,340,000	$425,106	$124,334	$7,835,495
Patrick J. Beyer	Chief Operating Officer	$501,460	$58,781	$0	$2,789,600	$165,318	$497,612	$4,012,771
Todd W. Garner	Executive Vice President, Finance and Chief Financial Officer	$521,653	$30,000	$0	$2,789,600	$171,124	$60,702	$3,573,079
Heather L. Cohen	Executive Vice President & Chief Human Resources and Legal Officer & Secretary	$408,775	$0	$0	$1,673,760	$111,056	$41,176	$2,234,767

Executive changes

Person	Role	Change	Effective	Filed
John E. Gallagher	Executive Vice President, Chief Financial Officer	Appointed	2026-07-15	2026-06-17
Kimberly Lockwood	Interim Corporate Controller	Appointed	2026-06-01	2026-05-20
Kimberly Lockwood	Interim Principal Accounting Officer	Appointed	2026-06-01	2026-05-20
Jeff Mirviss	director	Appointed	2026-07-01	2026-05-20
Celine Martin	director	Appointed	2026-07-01	2026-05-20
Andrew Moller	Interim Principal Financial Officer	Appointed	2026-03-15	2026-03-13
Kim Kelderman	director	Appointed	2025-09-08	2025-09-09
Martha Aronson	independent director	Resigned	2025-07-07	2025-07-07
Andrew Moller	Principal Accounting Officer	Appointed	2025-04-01	2025-04-01
Mark Kaye	director	Appointed	2025-02-24	2025-02-25
Pat Beyer	member of the Board	Appointed	2025-01-01	2024-10-30
Pat Beyer	President and Chief Executive Officer	Appointed	2025-01-01	2024-10-30
Todd W. Garner	Principal Accounting Officer	Appointed	—	2024-09-20
Kimberly A. Lockwood	Interim Corporate Controller	Appointed	2024-09-30	2024-09-20
Eric B. Staves	Vice President, Corporate Controller	Resigned	2024-09-27	2024-09-20
Stanley W. (Bill) Peters	President, Advanced Surgical & Advanced Endoscopic Technologies	Terminated	2024-08-31	2024-08-14
Eric B. Staves	Vice President, Corporate Controller	Appointed	2024-07-01	2024-05-28
Terence M. Berge	Vice President, Corporate Controller	Retired	2024-06-30	2024-05-28
Heather L. Cohen	Special Advisor	Appointed	2024-04-20	2024-04-24
Pat Beyer	Chief Operating Officer	Appointed	2024-04-24	2024-04-24
John (Jed) E. Kennedy	Group Executive Vice President, Advanced Endoscopic Technologies, QA/RA, Distribution and Customer Service	Retired	2022-04-01	2022-03-07

Key facts CIK 816956 CUSIP 207410101 13F (30d) 219 filings 219 filers Visit website Investor relations